20 January 2022
New research says lack of trust in public sector officials has played a key role in low uptake of COVID-19 vaccinations among groups termed 'high risk'.
14 January 2022
Dr Kanta Kumar together with rheumatology teams across the UK has played a key role in the Healthcare Quality Improvement Partnership report.
06 January 2022
Young men exposed to parasitic roundworm may be at increased risk of developing asthma and serious lung damage, a new study reveals.
04 January 2022
Professor Helen Stokes-Lampard, Chair of the Academy of Medical Royal Colleges and Professor of GP Education at the University of Birmingham, has been awarded a Damehood in the 2022 New Year Honours.
04 January 2022
Professor Iain Chapple, Professor of Periodontology and former Head of the School of Dentistry at the University of Birmingham, has been awarded an MBE in the 2022 New Year Honours.
04 January 2022
Scientists are calling for changes to healthcare policy following research showing the scale of the impact of a condition associated with benign tumours that can lead to type 2 diabetes and high blood pressure.
22 December 2021
A COVID-19 booster vaccination markedly increases immune response in residents and staff within care homes, making it vital that people living and working in these settings get their third 'jab', a new study reveals.
21 December 2021
Older patients in hospitals across China took part in a major multi-centre open-label randomised clinical trial that showed there was no difference in post-operative delirium in older people with a hip fracture.
20 December 2021
Adam Cunningham, Professor of Functional Immunity, speculates on how might the Omicron variant might affect future COVID-19 variants.
20 December 2021
A University of Birmingham-led study shows an increased risk of patients developing illnesses including mental ill-health and heart conditions if they have a GP-inputted medical history of gum disease.
20 December 2021
The University of Birmingham today announces the launch of five new major studies aimed at improving the prevention, treatment and management of type 1 diabetes – with a particular focus on children and young adults.
20 December 2021
A proof-of-concept trial has identified a drug that may offer benefit some patients hospitalised with COVID-19 pneumonia.